Endocrinology

At Medniqa, we believe quality healthcare is a fundamental right, not a privilege. We’re dedicated to ensuring that even the most remote communities have access to life-saving pharmaceutical products. We exist to turn pharmaceutical potential into patient impact.

Corporate Identity Number: U51391GJ2022PTC131260

Endocrinology

Alogliptin

Cinacalcet Hydrochloride

Dapagliflozin + Metformin

Empagliflozin

Empagliflozin + Linagliptin

Empagliflozin + Metformin

Linagliptin

Linagliptin + Metformin HCL

Raloxifene

Sitagliptin Phosphate Monohydrate

Sitagliptin Phosphate Monohydrate + Metformin HCL

Vildagliplin + Metformin

Vildagliptin

Solutions

Services

Resources:

Partner with Us: